Home » Finance
Limbach (NASDAQ:LMB) Shares Climb 12.9% on Analyst Upgrade
Shares of Limbach Holdings, Inc. (NASDAQ:LMB – Get Free Report) shot up 12.9% on Thursday after JPMorgan Chase & Co. raised their price target on the stock from $50.00 to $55.00. JPMorgan Chase & Co. currently has an... More of this article »
Astera Labs (NASDAQ:ALAB) Stock Gets Price Target Reduction from Royal Bank Of Canada
Astera Labs (NASDAQ:ALAB – Free Report) had its target price decreased by Royal Bank Of Canada from $500.00 to $400.00 in a research note released on Wednesday,Benzinga reports. Royal Bank Of Canada currently has an outperform... More of this article »
Shift4 Payments (NYSE:FOUR) Shares Gap Down – Here’s What Happened
Shift4 Payments, Inc. (NYSE:FOUR – Get Free Report) shares gapped down before the market opened on Thursday. The stock had previously closed at $44.82, but opened at $39.55. Shift4 Payments shares last traded at $37.69, with... More of this article »
Direxion Daily TSLA Bull 2X ETF (NASDAQ:TSLL) Shares Down 18.4% – Here’s What Happened
Direxion Daily TSLA Bull 2X ETF (NASDAQ:TSLL – Get Free Report)’s stock price dropped 18.4% during mid-day trading on Thursday. The stock traded as low as $8.45 and last traded at $8.4670. Approximately 15,056,868 shares... More of this article »
Calamos Wealth Management LLC Purchases 1,032,207 Shares of iShares MSCI ACWI ex U.S. ETF $ACWX
Calamos Wealth Management LLC acquired a new position in shares of iShares MSCI ACWI ex U.S. ETF (NASDAQ:ACWX – Free Report) in the third quarter, Holdings Channel.com reports. The firm acquired 1,032,207 shares of the company’s... More of this article »
Kinaxis (OTCMKTS:KXSCF) versus Life360 (NASDAQ:LIF) Critical Survey
Kinaxis (OTCMKTS:KXSCF – Get Free Report) and Life360 (NASDAQ:LIF – Get Free Report) are both mid-cap technology companies, but which is the superior investment? We will compare the two companies based on the strength of... More of this article »
Head to Head Analysis: BioAge Labs (NASDAQ:BIOA) versus InMed Pharmaceuticals (NASDAQ:INM)
InMed Pharmaceuticals (NASDAQ:INM – Get Free Report) and BioAge Labs (NASDAQ:BIOA – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based... More of this article »
AT&T Inc. $T Stock Sold by Calamos Advisors LLC
Calamos Advisors LLC reduced its stake in shares of AT&T Inc. (NYSE:T – Free Report) by 19.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 973,482... More of this article »
3M Company $MMM Position Raised by Calamos Advisors LLC
Calamos Advisors LLC grew its position in 3M Company (NYSE:MMM – Free Report) by 332.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 303,723 shares of the conglomerate’s stock after buying an additional... More of this article »
Calamos Advisors LLC Acquires 158,928 Shares of Emerson Electric Co. $EMR
Calamos Advisors LLC grew its holdings in Emerson Electric Co. (NYSE:EMR – Free Report) by 68.9% during the third quarter, HoldingsChannel.com reports. The firm owned 389,646 shares of the industrial products company’s... More of this article »
The Goldman Sachs Group, Inc. $GS Stock: Calamos Advisors LLC Decreases Position
Calamos Advisors LLC lessened its position in The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) by 9.8% in the 3rd quarter, Holdings Channel.com reports. The fund owned 149,509 shares of the investment management company’s... More of this article »
Calamos Advisors LLC Buys 17,544 Shares of ExxonMobil Corporation $XOM
Calamos Advisors LLC raised its stake in ExxonMobil Corporation (NYSE:XOM – Free Report) by 1.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned... More of this article »
Ocular Therapeutix (OCUL) & The Competition Financial Survey
Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) is one of 896 public companies in the “Pharmaceuticals” industry, but how does it compare to its competitors? We will compare Ocular Therapeutix to related companies... More of this article »
American Express Company $AXP Shares Sold by Calamos Wealth Management LLC
Calamos Wealth Management LLC decreased its position in shares of American Express Company (NYSE:AXP – Free Report) by 3.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission... More of this article »
Knight Therapeutics (TSE:GUD) Announces Earnings Results
Knight Therapeutics (TSE:GUD – Get Free Report) issued its quarterly earnings data on Thursday. The company reported C($0.03) earnings per share (EPS) for the quarter, FiscalAI reports. The firm had revenue of C$136.74 million... More of this article »
MDA Space (TSE:MDA) Issues Earnings Results
MDA Space (TSE:MDA – Get Free Report) posted its quarterly earnings data on Thursday. The company reported C$0.37 earnings per share (EPS) for the quarter, FiscalAI reports. MDA Space had a net margin of 5.66% and a return on... More of this article »
Sea Limited Sponsored ADR $SE Shares Purchased by CenterBook Partners LP
CenterBook Partners LP grew its holdings in Sea Limited Sponsored ADR (NYSE:SE – Free Report) by 404.1% during the third quarter, Holdings Channel reports. The firm owned 71,949 shares of the Internet company based in Singapore’s... More of this article »
Calamos Wealth Management LLC Makes New $4.33 Million Investment in Canadian Pacific Kansas City Limited $CP
Calamos Wealth Management LLC bought a new position in shares of Canadian Pacific Kansas City Limited (NYSE:CP – Free Report) (TSE:CP) during the third quarter, according to its most recent 13F filing with the Securities &... More of this article »
7,281 Quanta Services, Inc. $PWR Shares Acquired by CenterBook Partners LP
CenterBook Partners LP grew its stake in shares of Quanta Services, Inc. (NYSE:PWR – Free Report) by 493.3% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 8,757 shares of the construction... More of this article »
Insulet (NASDAQ:PODD) Stock Gets Price Target Increase from UBS Group
Insulet (NASDAQ:PODD – Get Free Report) had its price objective upped by stock analysts at UBS Group from $150.00 to $171.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has a “neutral”... More of this article »
66,946 Shares of LyondellBasell Industries N.V. $LYB Purchased by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of LyondellBasell Industries N.V. (NYSE:LYB – Free Report) during the third quarter, Holdings Channel reports. The fund acquired 66,946 shares of the specialty... More of this article »
Mirae Asset Global Investments Co. Ltd. Makes New Investment in CDW Corporation $CDW
Mirae Asset Global Investments Co. Ltd. bought a new stake in CDW Corporation (NASDAQ:CDW – Free Report) during the 3rd quarter, HoldingsChannel reports. The firm bought 32,329 shares of the information technology services provider’s... More of this article »
43,998 Dimensional Short-Duration Fixed Income ETF $DFSD Shares Sold by MGO One Seven LLC
MGO One Seven LLC cut its holdings in Dimensional Short-Duration Fixed Income ETF (NYSEARCA:DFSD – Free Report) by 72.4% in the third quarter, Holdings Channel reports. The fund owned 16,763 shares of the company’s stock... More of this article »